Thematic Report on India Diagnostics: The Great Consolidation and the Rise of Organized Chains
​Indian diagnostic sector shifts focus from pandemic testing to sustainable growth drivers, with listed players poised to gain market share from...
213 Views
Metropolis Healthcare - Soft Quarter; Outlook Remains Promising
MHL’s Q3FY25 EBITDA missed street/our estimates by 9%/4%, with revenue growing 11% YoY driven by B2C revenue improving 15% YoY.
376 Views
Metropolis Healthcare - Growth Levers Adequately in Place
Metropolis’ Q3FY25 result was impacted by lower sales from institutional biz (2% impact on revenue) and muted growth in acute ailment tests.
361 Views
Metropolis Healthcare - Inorganic Foray into Non-Core Markets; Scalability Key Monitorable
MHL announced its acquisition of Core Diagnostics—an oncology focused diagnostics chain with majority of its revenue derived from North/East India—...
281 Views
Metropolis Healthcare: Core Diagnostic M&A to Strengthen Speciality Portfolio.
Metropolis signed a definite agreement to acquire a 100% stake in Core Diagnostics. This acquisition will strengthen its advanced cancer testing...
412 Views